US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors ...Middle East

PR Newswire - News
US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors
The liquid biopsy has been developed by Datar Cancer Genetics to help diagnose brain tumors where a conventional biopsy is not possible. A prospective, blinded study by a research team at the Imperial College, London showed very high accuracy in detecting malignant brain tumors. Datar...

Read More Details
Finally We wish PressBee provided you with enough information of ( US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors )

Also on site :